Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES Gains 3%; BSE HEALTHCARE Index Down 0.4%
Wed, 25 Sep 14:59

ALKEM LABORATORIES Gains 3%; BSE HEALTHCARE Index Down 0.4%Image source: Sefa Ozel/www.istockphoto.com

ALKEM LABORATORIES share price has zoomed 3% and is presently trading at Rs 6,252.0.

Meanwhile, the BSE HEALTHCARE index is at 44,043.1 (down 0.4%).

Among the top gainers in the BSE HEALTHCARE index today are NARAYANA HRUDAYALAYA (up 2.3%) and Jubilant Pharmova (up 1.1%).

MAX HEALTHCARE INSTITUTE (down 4.2%) and ASTRAZENECA PHARMA (down 4.2%) are among the top losers today.

Over the last one year, ALKEM LABORATORIES has moved up from Rs 3,551.9 to Rs 6,252.0, registering a gain of Rs 2,700.1 (up 76.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,800.9 to 44,043.1, registering a gain of 58.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 183.9%), SUVEN PHARMACEUTICALS (up 126.5%) and Glenmark Pharma (up 114.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 84,970.2 (up 0.1%).

The top gainers among the BSE Sensex today are Power Grid Corp. (up 3.8%) and Axis Bank (up 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.

In the meantime, NSE Nifty is at 25,936.8 . LTIMINDTREE and Tech Mahindra are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,023.7 to 84,970.2, registering a gain of 18,946.5 points (up 28.7%).

ALKEM LABORATORIES Financial Update...

ALKEM LABORATORIES net profit grew 91.2% YoY to Rs 5,502 million for the quarter ended June 2024, compared to a profit of Rs 2,878 million a year ago. Net sales rose 2.2% to Rs 30,318 million during the period as against Rs 29,677 million in April-June 2023.

For the year ended March 2024, ALKEM LABORATORIES reported 79.9% increase in net profit to Rs 18,115 million compared to net profit of Rs 10,068 million during FY23. Revenue of the company grew 9.2% to Rs 126,676 million during FY24.

The current Price to earnings ratio of ALKEM LABORATORIES, based on rolling 12 month earnings, stands at 36.0.


Equitymaster requests your view! Post a comment on "ALKEM LABORATORIES Gains 3%; BSE HEALTHCARE Index Down 0.4%". Click here!